Detalles de la búsqueda
1.
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.
Blood
; 143(5): 444-455, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883802
2.
Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.
Mol Cell
; 69(1): 146-157.e3, 2018 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304331
3.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
4.
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol
; 113(12): 696, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390030
5.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol
; 113(9): 1345, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946178
6.
The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers.
Nucleic Acids Res
; 44(15): 7385-94, 2016 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27174938
7.
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression.
Nucleic Acids Res
; 43(1): 674-81, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25326321
8.
Current and future prospects for CRISPR-based tools in bacteria.
Biotechnol Bioeng
; 113(5): 930-43, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460902
9.
Development of a Digital Patient Assistant for the Management of Cyclic Vomiting Syndrome: Patient-Centric Design Study.
JMIR Form Res
; 8: e52251, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38842924
10.
Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn's disease: results from the EVOLVE study.
Eur J Gastroenterol Hepatol
; 36(3): 281-291, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179874
11.
Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.
Mol Oncol
; 18(1): 113-135, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971174
12.
The EV antibody database: An interactive database of curated antibodies for extracellular vesicle and nanoparticle research.
Extracell Vesicle
; 32024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38872853
13.
Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis.
PLoS One
; 18(10): e0292231, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788264
14.
Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn's Disease.
Crohns Colitis 360
; 4(4): otac048, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36778514
15.
Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review.
Crohns Colitis 360
; 4(3): otac020, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36777427
16.
Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.
Health Qual Life Outcomes
; 9: 36, 2011 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21600054
17.
Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
Inflamm Bowel Dis
; 26(3): 462-468, 2020 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30980714
18.
Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis.
J Crohns Colitis
; 14(5): 575-587, 2020 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31901085
19.
Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome.
Therap Adv Gastroenterol
; 12: 1756284818818326, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30636972
20.
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.
Inflamm Bowel Dis
; 25(11): 1854-1861, 2019 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050734